SCHEDULE 13G: Bain Capital Affiliate Discloses Majority Stake in Kestra Medical Technologies

Bain Charger Holdings, L.P., an affiliate of Bain Capital, has disclosed a beneficial ownership of 52.6% in Kestra Medical Technologies, Ltd., primarily through shared voting and dispositive power.

Summary

• Bain Charger Holdings, L.P. (the "Reporting Person"), a Delaware limited partnership, has filed a Schedule 13G indicating significant beneficial ownership in Kestra Medical Technologies, Ltd.
• As of March 31, 2025, the Reporting Person beneficially owns an aggregate of 27,019,225 Common Shares of Kestra Medical Technologies, Ltd.
• This ownership represents 52.6% of the Issuer's outstanding Common Shares, based on 51,348,656 Common Shares outstanding as of April 17, 2025.
• The ownership includes 7,109,944 Common Shares directly held by Bain Charger Holdings, L.P., representing approximately 13.8% of outstanding shares.
• Additionally, 19,909,281 Common Shares are directly held by West Affum Holdings, L.P. ("West Affum"), representing approximately 38.8% of outstanding shares, for the benefit of West Affum common unit holders, including the Reporting Person.
• Bain Capital Investors, LLC, the general partner of Bain Charger Holdings, L.P., may be deemed to share voting and dispositive power over these securities.
• The Reporting Person has shared voting power over 24,949,838 Common Shares and shared dispositive power over 27,019,225 Common Shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While a Schedule 13G is a factual disclosure, the revelation of a majority stake by a reputable institutional investor like Bain Capital can be perceived positively by the market, indicating strong backing and potential for strategic direction, which could be beneficial for the company's future.

Positives

• The disclosure of a significant beneficial ownership by a major institutional investor like Bain Capital (through its affiliate) can signal strong institutional confidence in Kestra Medical Technologies, Ltd.
• A majority stake by a sophisticated investor may imply strategic support and potential for long-term stability or growth initiatives for the company.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Kestra Medical Technologies, Ltd.'s future outlook.

Industry Context

This filing indicates a significant investment by a prominent private equity firm, Bain Capital, into a medical technology company. Such investments are common in the healthcare sector, where private equity often seeks to capitalize on growth opportunities, technological advancements, and market consolidation. A majority stake suggests a strong belief in the company's potential within the competitive medical device industry.

Stakeholder Impact

• Shareholders: The disclosure of a majority beneficial owner, Bain Capital, could influence investor perception, potentially leading to increased confidence due to institutional backing or concerns regarding liquidity and control concentration.
• Company Management: The significant ownership by Bain Capital may imply increased oversight or strategic influence from the investor in the company's operations and future direction.

Key Dates

Keywords

Kestra Medical Technologies, Bain Capital, Bain Charger Holdings, Schedule 13G, Beneficial Ownership, Institutional Investor, Medical Devices, Healthcare Technology, Equity Stake, Common Shares